494 related articles for article (PubMed ID: 17089236)
21. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
López-Boado YS; Rubin BK
Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis of high doses of ambroxol treatment for acute lung injury/acute respiratory distress syndrome based on randomized controlled trials.
Wu X; Li S; Zhang J; Zhang Y; Han L; Deng Q; Wan X
J Clin Pharmacol; 2014 Nov; 54(11):1199-206. PubMed ID: 25174313
[TBL] [Abstract][Full Text] [Related]
23. [Antenatal ambroxol administration for prevention of respiratopry distress syndrome in preterm infants: preliminary report].
Marinov B; Jekova N; Andreeva A; Hitrova S
Akush Ginekol (Sofiia); 2011; 50(4):17-22. PubMed ID: 22479892
[TBL] [Abstract][Full Text] [Related]
24. [Effect of a secretolytic and a combination of pinene, limonene and cineole on mucociliary clearance in patients with chronic obstructive pulmonary disease].
Dorow P; Weiss T; Felix R; Schmutzler H
Arzneimittelforschung; 1987 Dec; 37(12):1378-81. PubMed ID: 3449066
[TBL] [Abstract][Full Text] [Related]
25. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy.
Gillissen A; Nowak D
Respir Med; 1998 Apr; 92(4):609-23. PubMed ID: 9659525
[TBL] [Abstract][Full Text] [Related]
26. [Inhalation and peroral mucolytic therapy in mucoviscidosis in children].
Uglitskikh AK; Khan MA; Sharapov SV; Kapranov NI; Plisko LF
Vopr Kurortol Fizioter Lech Fiz Kult; 1996; (5):15-8. PubMed ID: 9036657
[TBL] [Abstract][Full Text] [Related]
27. Expanded use of surfactant therapy in newborns.
Lacaze-Masmonteil T
Clin Perinatol; 2007 Mar; 34(1):179-89, ix. PubMed ID: 17394937
[TBL] [Abstract][Full Text] [Related]
28. [Effect of mucolytic therapy on the production of reactive oxygen species in the blood of patients with an exacerbation of chronic obstructive pulmonary disease].
Farkhutdinov UR; Farkhutdinov RR; Petriakov VV; Farkhutdinov ShU; Mirkhaĭdarov AM
Ter Arkh; 2010; 82(3):29-32. PubMed ID: 20564918
[TBL] [Abstract][Full Text] [Related]
29. Antenatal use of ambroxol for the prevention of infant respiratory distress syndrome.
Laoag-Fernandez JB; Fernandez AM; Maruo T
J Obstet Gynaecol Res; 2000 Aug; 26(4):307-12. PubMed ID: 11049243
[TBL] [Abstract][Full Text] [Related]
30. Ambroxol for prophylaxis and treatment of bronchopulmonary complications after chest surgery.
Romanini BM; Sandri MG; Tosi M; Mezzetti M; Mazzetti A
Int J Clin Pharmacol Res; 1986; 6(2):123-7. PubMed ID: 3522443
[TBL] [Abstract][Full Text] [Related]
31. Exogenous surfactant in acute respiratory distress syndrome: more is better.
Anzueto A
Eur Respir J; 2002 May; 19(5):787-9. PubMed ID: 12030713
[No Abstract] [Full Text] [Related]
32. Inhaled mannitol for the treatment of cystic fibrosis.
Hurt K; Bilton D
Expert Rev Respir Med; 2012 Feb; 6(1):19-26. PubMed ID: 22283575
[TBL] [Abstract][Full Text] [Related]
33. Perspectives for use of surfactant in children and adults.
Marraro GA
J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():29-31. PubMed ID: 15590431
[TBL] [Abstract][Full Text] [Related]
34. [Effectiveness of lasolvan in patients with chronic obstructive bronchitis and non-atopic bronchial asthma].
Aleksa VI; Prozorova VK; Mal'tseva NA; Shatikhina LN
Ter Arkh; 2001; 73(3):48-51. PubMed ID: 11417181
[TBL] [Abstract][Full Text] [Related]
35. The potential role of natural agents in treatment of airway inflammation.
Sharafkhaneh A; Velamuri S; Badmaev V; Lan C; Hanania N
Ther Adv Respir Dis; 2007 Dec; 1(2):105-20. PubMed ID: 19124352
[TBL] [Abstract][Full Text] [Related]
36. [Ambroxol. Prophylaxis and therapy of pulmonary complications. Symposium on the occasion of the 12th International Sylt Week on Anesthesiology. 9 September 1998].
Anaesthesist; 1998 Nov; 47(11 Suppl Prophylaxe):1-12. PubMed ID: 9884733
[No Abstract] [Full Text] [Related]
37. Advances in respiratory therapeutics in children.
Reisman JJ
Curr Opin Pediatr; 1993 Apr; 5(2):216-22. PubMed ID: 8104076
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary surfactant therapy.
Jobe AH
N Engl J Med; 1993 Mar; 328(12):861-8. PubMed ID: 8441430
[No Abstract] [Full Text] [Related]
39. [Stimulation of fetal lung development].
Leszczyńska-Grzelak B; Oleszczuk J
Wiad Lek; 1995; 48(1-12):227-9. PubMed ID: 9638246
[No Abstract] [Full Text] [Related]
40. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature.
Boogaard R; de Jongste JC; Merkus PJ
Pediatr Pulmonol; 2007 Nov; 42(11):989-1001. PubMed ID: 17902149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
